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ABSTRACT
Introduction: Antibiotic stewardship programs
(ASP) improve appropriate antibiotic use. Data
are limited on the clinical benefit of ASPs in
children’s hospitals. This study’s objective was
to determine the impact of an ASP on length of
stay (LOS) and readmission rate among patients
admitted to children’s hospitals.
Methods: Data from a prospective-audit-
with-feedback ASP were used to examine the
ASP review characteristics, including
antibiotic(s) prescribed, clinical indication,
recommendations made by the ASP, and
agreement with recommendations. Propensity
score analysis was utilized to determine the
impact of the ASP on LOS and 30-day
readmission based on whether the patient
received an ASP recommendation and if the
clinician agreed with recommendations.
Patients were stratified on if they had a
complex chronic condition status (CCC) and
their service line, medical or surgical.
Results: Of the 8038 reviews included, 1362
(16.9%) resulted in a recommendation that was
agreed with in 1116 (81%) cases. Propensity
score analysis demonstrated a significantly
longer LOS for the non-CCC medicine group
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who received an ASP recommendation (80.9 vs.
67.6 h, p\0.001). However, for CCC medicine
patients that agreed with the ASP
recommendation, a clinically relevant decrease
in LOS (158.1 vs. 180.3 h, p = 0.095) was
observed. The 30-day readmission rate was
significantly greater in CCC medicine patients
when comparing those who did not receive a
recommendation versus those who did receive a
recommendation (7.3% vs 4.2%, respectively;
p = 0.005).
Conclusion: Children without a CCC who
received an ASP recommendation had a longer
length of stay. For children with CCCs, the ASP
appeared to decrease LOS and significantly
reduce 30-day readmission rates. Overall, this
study demonstrate that ASPs offer meaningful
clinical benefit justifying resource allocation
needed to develop and maintain ASP programs.
Keywords: Antibiotic stewardship; Length of
stay; Outcomes; Readmission
INTRODUCTION
Antibiotic resistant bacteria kill 23,000
Americans and infect another 2 million
annually [1]. Compounding this problem is
the lack of new antibiotics targeted against the
most highly resistant bacteria such as
carbapenem-resistant Enterobacteriaceae
(CRE). Antibiotic stewardship programs have
been implemented in hospitals to improve the
use of antibiotics and limit the unnecessary
antibiotic pressure that contributes to antibiotic
resistance.
Antibiotic stewardship programs (ASP) have
been valuable in children’s hospitals. Many
pediatric ASPs have significantly reduced the
overall use of antibiotics without a reported
increase in patient harm or antibiotic resistance
[2, 3]. Furthermore, these programs have been
associated with an up to US$200,000 reduction
in antibiotic acquisition costs [4]. Finally,
pediatric clinicians impacted by ASPs believe
these programs improve the overall care of
patients and provide knowledge about the
appropriate use of antibiotics [5].
Nevertheless, data are limited on whether a
pediatric ASP results in a clinical benefit for
hospitalized children. Among adult hospital
ASPs, studies have demonstrated a decrease in
the length of stay in the medical ICU, a
reduction in Clostridium difficile rates, and an
improvement in antibiotic susceptibilities of
common pathogens [6–8]. The objective of
this study was to determine the impact of a
children’s hospital ASP on hospital length of
stay (LOS) and rate of readmission.
METHODS
Study Design, Setting and Data Sources
A single-center cohort study was performed at a
quaternary care freestanding 354-bed children’s
hospital. On March 3, 2008 a
prospective-audit-with-feedback ASP was
implemented, focused on delineating
appropriateness of antibiotic use in children
who had received a defined group of antibiotics
(Supplemental Table 1) for two calendar days
[3, 5]. An infectious diseases (ID) pharmacist
and ID physician reviewed the clinical data and
provided recommendations that were
categorized into four areas: (1) stop therapy,
(2) modify the antibiotic type, (3) modify the
antibiotic dosage and/or duration and (4)
obtain an ID consultation [9].
The ASP repository was utilized to capture
the data collected on each patient review
including: antibiotic(s) prescribed, antibiotic
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indication, dose of antibiotic(s), clinical
indication, length of therapy, and
recommendations made by the ASP. After
verbal feedback to the provider, agreement or
disagreement with recommendations was
confirmed and, for those who agreed,
compliance and follow through with
recommendations was documented. Since a
patient could be reviewed by the ASP more
than once during an admission, each patient
encounter was referred to as a review. Patients’
demographic data as well as the length of
hospitalization was obtained from the
electronic health record. Data from the ASP
repository was merged with the corresponding
hospital data in Pediatric Health Information
System (PHIS) database in order to obtain
additional data elements.
The PHIS database was utilized to identify
patients with complex chronic care
condition(s) (CCC) ICD9 discharge diagnosis
codes [10] and to determine the prevalence of
30-day readmission for the same all-patient
refined diagnosis-related groups (APR-DRG).
PHIS is an administrative database that
contains inpatient, emergency department,
ambulatory surgery and observation data from
48 not-for-profit, tertiary care pediatric
hospitals in the United States. These hospitals
are affiliated with the Children’s Hospital
Association (Mission, KS, USA). Data quality
and reliability are assured through a joint effort
between the Children’s Hospital Association
and participating hospitals. The data
warehouse function for the PHIS database is
managed by Truven Health Analytics (Ann
Arbor, MI, USA). For the purposes of external
benchmarking, participating hospitals provide
discharge/encounter data including
demographics, diagnoses, and procedures.
Nearly all of these hospitals also submit
resource utilization data (e.g., pharmaceuticals,
imaging, and laboratory) into PHIS. Data are
de-identified at the time of data submission and
data are subjected to a number of reliability and
validity checks before being included in the
database. Using internal patient identifiers, the
repository data was merged with the data
obtained from PHIS.
Compliance with Ethics Guidelines
This article does not contain any new studies
with human or animal subjects performed by
any of the authors. This study was approved by
Children’s Mercy Hospital’s institutional review
board.
Study Population
The study population included all individuals
with a single ASP review from March 3, 2008 to
March 2, 2014. Data were analyzed related to
the APR-DRG medical or surgical category, and
the presence of a CCC ICD9 code. Children
admitted to the pediatric intensive care unit,
neonatal intensive care unit, hematology/
oncology unit, those who died, and those with
more than one ASP review during their
hospitalization were excluded from the
analysis.
Outcomes
The primary outcomes were hospital LOS and
30-day hospital readmission rates. Length of
stay was calculated as the number of hours
between the patients’ admission and discharge
from the hospital. A patient was included in the
30-day readmission rate if PHIS assessed data
confirmed they were readmitted as an inpatient
to the hospital within 30 days of the prior
discharge with the same APR-DRG as the prior
hospitalization.
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Statistical Analysis
First, unadjusted differences in LOS and
readmission based on two separate ‘‘treatment’’
indicators were calculated. The first indicator
was whether the ASP provider gave a
recommendation related to the patient’s
antibiotic regimen. The second indicator
focused on those receiving a recommendation,
related to agreement or disagreement with the
recommendations. Both treatment indicators
were modeled as binary indicators.
Adjusted differences in the primary
outcomes were then calculated using inverse
probability-weighted (IPW) estimates as a
means to control for possible confounding.
The propensity score was calculated using
multiple factors that were hypothesized to be
related to an ASP recommendation: (1) patient’s
age and sex, (2) year since the ASP program was
implemented, (3) clinical indication for
antibiotic treatment, (4) the prescribed
antibiotic(s), (5) patient’s CCC status, and 6)
the clinical service line. In an effort to increase
statistical efficiency, we utilized stabilized IPWs
[11–13]. We hypothesized that LOS and
readmission would be significantly related to
the patient’s clinical service and the underlying
chronic conditions. Consequently, we stratified
all analysis by four distinct categories: (1) CCC
Surgical, (2) Non-CCC Surgical, (3) Non-CCC
Medicine and (4) CCC Medicine.
All analyses were completed with Stata
software (v.13.1; StataCorp, College Station,
TX, USA). For the unadjusted analysis, the
median LOS was calculated and the Wilcoxon
Rank-Sum test used to determine statistical
significance, while the prevalence of
readmission was compared using Fisher’s exact
test. A p value \0.05 was used to determine
statistical significance. Quintile and logistic
regression models were used for calculating
IPW estimates. We report the difference in
median LOS and difference in proportion
readmitted. List-wise deletion was done for
instances where agreement status was not
documented.
RESULTS
ASP providers performed 17,422 reviews during
the study period. Patients admitted to the PICU
(n = 1707), the NICU (n = 1893), or the
hematology/oncology service (n = 3460), who
had more than one review (n = 2038), who had
incomplete data for analysis (n = 261) or who
died (n = 25) were excluded, resulting in 8038
total reviews for analysis. Among the total 8038
reviews, 1362 (16.9%) resulted in a
recommendation which was agreed with in
1116 (81.9%) cases.
Table 1 shows the demographic/clinical
characteristics by the four CCC categories
that were included in this study. Patients
classified as CCC surgical had the highest
percentage of recommendations (28.1%) while
non-CCC surgical had the lowest (8.9%).
Disagreement with recommendations was
highest in patients who were classified as
having a CCC (Fig. 1).
Suspected sepsis was the most frequently
identified indication for antibiotics among
non-CCC medicine children (n = 1060) and
ceftriaxone was the most common ASP
monitored-antibiotic prescribed in those
patients (Supplemental Fig. 1, 2). An
ASP-monitored drug plus concurrent
metronidazole was most commonly identified
among surgical patients. Patients with CCCs
most commonly received an ASP-monitored
drug plus concurrent clindamycin;
additionally, this group of patients often had
two or more indications for antibiotics being
prescribed. Overall, those with
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community-acquired pneumonia had the
highest percentage of recommendations
(35.8%; Supplemental Fig. 2).
Outcomes
The unadjusted median LOS between children
receiving a recommendation versus no
recommendation was similar in 2 of the 4
groups (Table 2). Non-CCC medicine children
who received an ASP recommendation had a
significantly longer median LOS than children
who did not receive a recommendation (81.5 vs.
66.4 h, p\0.001). A significantly longer LOS
was also observed for the non-CCC surgery
group (difference of 5 h, p = 0.015). Differences
in length of stay were not statistically
significant when evaluating based upon
agreement with the ASP recommendations
(Table 3). When disagreement with ASP










Male, n (col. %) 692 (59.0%) 288 (55.0%) 2024 (49.5%) 1192 (53.0%)
Age
0–5 months 20 (1.7%) 123 (23.5%) 1971 (48.2%) 287 (12.8%)
6–17 months 28 (2.4%) 74 (14.1%) 443 (10.8%) 240 (10.7%)
18–59 months 176 (15.0%) 101 (19.3%) 593 (14.5%) 387 (17.2%)
5–12 years 644 (54.9%) 119 (22.7%) 731 (17.9%) 550 (24.4%)
13? years 304 (25.9%) 107 (20.4%) 354 (8.7%) 786 (34.9%)
ASP year
1 193 (16.5%) 96 (18.3%) 940 (23.0%) 418 (18.6%)
2 205 (17.5%) 102 (19.5%) 826 (20.2%) 403 (17.9%)
3 199 (17.0%) 93 (17.7%) 721 (17.6%) 360 (16.0%)
4 215 (18.3%) 91 (17.4%) 608 (14.9%) 388 (17.2%)
5 196 (16.7%) 82 (15.6%) 505 (12.3%) 328 (14.6%)
6 164 (14.0%) 60 (11.5%) 492 (12.0%) 353 (15.7%)
Primary insurance
Medicaid 430 (36.7%) 226 (43.1%) 1983 (48.5%) 1074 (47.7%)
Commercial 614 (52.4%) 260 (49.6%) 1725 (42.2%) 938 (41.7%)
Self-pay 83 (7.1%) 10 (1.9%) 223 (5.4%) 75 (3.3%)
Other/unknown 45 (3.8%) 28 (5.3%) 161 (3.9%) 163 (7.2%)
Any recommendations 104 (8.9%) 147 (28.1%) 638 (15.6%) 473 (21.0%)
Disagreed with recommendations,
N/n (col. %)
17/98 (17.3%) 32/134 (23.9%) 105/611 (17.2%) 92/448 (20.5%)
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recommendations was documented in the
CCC-medicine group, a 28 h longer
hospitalization was observed (p = 0.101).
After performing the IPW analysis, the LOS
remained significantly longer for the non-CCC
medicine group who received a
recommendation (Table 2; 80.9 vs. 67.6 h,
p\0.001). Differences in median LOS
remained non-significant for all four groups
when comparing agreement status. The median
LOS was longer for CCC medicine patients
when there was disagreement with
recommendations versus agreement; however,
this was not determined to be statistically
significant (180.3 vs. 158.1, p = 0.095).
Differences in the unadjusted 30-day
readmission rate were non-significant for all 4
groups (Tables 4, 5). After performing IPW
analysis, the readmission rate was significantly
greater in children on a medicine service with a
CCC that did not receive a recommendation
versus those who did receive a recommendation
(7.3% vs 4.2%, p = 0.005). The readmission
rates for CCC surgery patients without a
Fig. 1 The percent of disagreement by patient group and
recommendation type
Table 2 Comparison of length of stay (LOS) between patients with an ASP recommendation and patients without a
recommendation, by complex chronic conditions (CCC) status and medicine/surgical service line
N Unadjusted Inverse-probability weighted
Median LOS 95% CI p value Median LOS 95% CI p value
Lower Upper Lower Upper
Non-CCC, surgery
Recommendations 104 120.42 114.25 138.06 0.015 115.60 104.77 126.43 0.955
No Recommendations 1068 115.20 112.72 118.80 115.27 111.78 118.77
CCC, surgery
Recommendations 147 214.89 186.74 265.09 0.286 214.63 175.79 253.47 0.998
No Recommendations 377 213.25 182.01 251.26 214.56 185.88 243.24
Non-CCC, medicine
Recommendations 638 81.46 75.77 85.82 \0.001 80.86 78.43 83.30 \0.001
No Recommendations 3454 66.41 65.06 67.68 67.61 66.24 68.99
CCC, medicine
Recommendations 473 156.78 140.57 168.28 0.575 184.27 168.63 199.90 \0.001
No Recommendations 1777 162.67 145.24 169.67 150.48 139.97 160.99
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recommendation was 1.7% higher than those
who received a recommendation, though that
difference was not statistically significant
(p = 0.078). No statistically significant
differences in readmission rates were observed
based upon agreement status in either the
unadjusted or IPW analyses.
DISCUSSION
We present the largest study to date evaluating
the impact of an ASP on length of stay and
readmission rates in patients hospitalized at a
children’s hospital. Length of stay was observed
to be longer for non-CCC children admitted to
a medical service who received an ASP
recommendation, regardless of acceptance. In
contrast, a shorter LOS (22 h) was identified in
children with CCCs hospitalized on a medicine
service when providers agreed with the ASP
recommendation. Readmissions were more
common for all patients that did not generate
an ASP recommendation.
As hospitals continue to develop and
implement ASPs, studies evaluating both
positive clinical benefits and possible negative
outcomes are necessary. In this study, we
hypothesized a significant positive clinical
benefit would be observed through a decrease
in LOS and decrease in 30-day readmission rate.
In a previous study, we demonstrated that
among patients admitted to a hospitalist
service LOS was longer for patients having an
ASP recommendation that was agreed upon by
the hospitalist service [14]. In this study, which
evaluated patients admitted to hospitalist and
general pediatric services, the LOS was increased
for non-CCC medicine patients receiving an
ASP recommendation but was not increased
when comparing whether the provider agreed
Table 3 Comparison of length of stay (LOS) between clinician
disagreement with ASP recommendation and agreement with a
recommendation, by complex chronic conditions (CCC) status and
medicine/surgical service line (agreement status was not recorded for
all patients)
N Unadjusted Inverse-probability weighted
Median
LOS
95% CI p value Median
LOS
95% CI p value
Lower Upper Lower Upper
Non-CCC,
surgery
Disagreed 17 136.10 119.89 208.26 0.214 136.68 111.32 162.04 0.258
Agreed 81 118.11 111.59 141.78 118.11 98.35 137.87
CCC, surgery
Disagreed 32 236.31 153.46 420.41 0.569 214.63 141.29 287.97 0.943
Agreed 102 208.39 183.03 265.93 211.35 160.69 262.02
Non-CCC,
medicine
Disagreed 105 84.25 72.09 92.55 0.603 84.58 75.38 93.77 0.487
Agreed 506 80.81 74.67 86.07 80.90 76.09 85.71
CCC, medicine
Disagreed 92 174.89 143.56 241.06 0.101 180.33 159.66 201.01 0.095
Agreed 356 146.33 138.32 168.06 158.05 142.09 174.01
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or disagreed with the ASP recommendation.
The increase in LOS seen among patients
receiving a recommendation by the ASP and
not based upon agreement status could be the
result of the patients requiring a
recommendation having a more serious illness
that we were unable to account for in our
analysis.
Children with a CCC on a medicine service
had almost a 1-day decrease in LOS when a
provider agreed with the ASP. Previously, we
identified stopping antibiotics as the most
common ASP recommendation and
demonstrated that disagreements with ASP
recommendations most often occurred related
to narrowing use of broad-spectrum antibiotics
(e.g., linezolid, carbapenems) and among
diagnoses such as tracheitis [3, 9]. Similar
disagreements in the CCC patients identified
in this study may have led to longer durations
of these broad-spectrum antimicrobial therapies
and longer lengths of stay.
In addition to a reduction in LOS, children
with CCCs in whom an ASP recommendation
was made experienced a 3% decrease in 30-day
readmission rates. Preventable readmissions
among children with CCCs provide an excess
burden to families and patients and are
associated with significant avoidable hospital
costs. In previous years, children’s hospitals
have seen an increase in admissions among
children with CCCs [15]. Data have shown that
children with CCCs are often readmitted and
the greater number of CCCs a child has
Table 4 Comparison of 30-day readmission between patients with an ASP recommendation and patients without a
recommendation, by complex chronic conditions (CCC) status and medicine/surgical service line
N Unadjusted Inverse-probability weighted
Readmitted
(%)
95% CI p value Readmitted
(%)
95% CI p value
Lower Upper Lower Upper
Non-CCC, surgery
Recommendations 104 0.00% – – 0.615
No
Recommendations
1068 1.12% 0.64% 1.97%
CCC, surgery
Recommendations 147 0.68% 0.09% 4.72% 0.296 0.56% 0.07% 4.32% 0.078
No
Recommendations
377 2.39% 1.24% 4.53% 2.26% 1.17% 4.34%
Non-CCC, medicine
Recommendations 638 2.82% 1.78% 4.44% 0.393 2.44% 1.47% 4.03% 0.834
No
Recommendations
3454 2.26% 1.81% 2.81% 2.30% 1.85% 2.85%
CCC, medicine
Recommendations 473 4.86% 3.25% 7.22% 0.064 4.21% 2.76% 6.36% 0.005
No
Recommendations
1777 7.37% 6.24% 8.68% 7.29% 6.17% 8.59%
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increases the risk [16]. Many factors impact the
care of these complex children, but our data
suggest that input from ASP providers can
positively impact the care for these children
and may result in significant cost savings. The
findings from this study also support that
enforcing the judicious use of antimicrobials
did not have undesired implications such as an
increase in readmission rates.
This study has several limitations. First, we
did not include all patients reviewed by our
ASP. This could result in underestimating the
impact of the ASP as data have shown that
intensive care unit lengths of stay have been
significantly reduced by the presence of ASPs
[6]. Second, this study was done at one
institution with an ASP that focuses on the use
of prospective-audit with feedback. Other ASPs
utilizing different strategies potentially could
find similar to greater success in the reduction
of LOS and readmission rates. Finally, while we
tried to account for severity of illness within our
comparison groups by performing IPW
analyses, we recognize that there are
unmeasured confounders that may have
impacted our propensity score calculations
and potentially affected the exchangeability of
treatment groups.
CONCLUSION
This study demonstrates the clinical impact that
is realized when a formal ASP is implemented in
a children’s hospital. For hospitalized children
with CCCs whose care resulted in an ASP
intervention, shorter hospital stays and less
readmissions were confirmed. As health care
models for reimbursement continue to change
Table 5 Comparison of 30-day readmission between clinician
disagreement with ASP recommendation and agreement with a
recommendation, by complex chronic conditions (CCC) status and
medicine/surgical service line (agreement status was not recorded for
all patients)
N Unadjusted Inverse-probability weighted
Readmitted
(%)
95% CI p value Readmitted
(%)
95% CI p value
Lower Upper Lower Upper
Non-CCC,
surgery
Disagreed 17 0.00% – – – 0.00% – – –
Agreed 81 0.00% – – 0.00% – – –
CCC, surgery
Disagreed 32 0.00% – – 1.000 0.00% – – –
Agreed 102 0.98% 0.13% 6.80%
Non-CCC,
medicine
Disagreed 105 2.86% 0.92% 8.55% 1.000 3.86% 1.42% 10.02% 0.655
Agreed 506 2.96% 1.79% 4.87% 2.93% 1.77% 4.82%
CCC, medicine
Disagreed 92 5.43% 2.26% 12.48% 0.781 4.87% 1.99% 11.42% 0.972
Agreed 356 4.49% 2.77% 7.22% 4.78% 2.99% 7.56%
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toward a bundled payment model, the presence
of a formal ASP in a hospital is essential to
ensure optimal care for patients, and especially
for those with special healthcare needs. Future
research is needed to understand the impact on
specific patient populations (e.g., PICU, NICU,
hematology-oncology) for which ASPs might
have the greatest clinical impact and to add
support for the resources necessary for
development and implementation of these
important hospital programs.
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